United States

Magazine articles on politics and society in the United States.

Old Articles: <Older 7531-7540 Newer>

Food Processing December 2007 Leslie Krasny	Eye On: Regulatory Issues The most pressing regulatory issues of 2008.
ifeminists December 15, 2007 Tony Zizza	Is Michael Vick A Yard Short Of Redemption? The defense tactics by Michael Vick's lawyer fall short of believable.
InternetNews December 14, 2007 Larry Barrett	FTC Chairman Stays Put in Google-DoubleClick Review Federal Trade Commission Chairman Deborah Platt Majoras dismisses conflict-of-interest charges and refuses to recuse herself from overseeing the Google-DoubleClick investigation.
The Motley Fool December 14, 2007 Seth Jayson	Senate Passes Taxpayer Subprime Bailout The Senate, nearly unanimously, passed a bill that would allow the Federal Housing Administration to insure bigger mortgages with lower down payments.
InternetNews December 13, 2007 Sean Gallagher	Consumer, Industry Groups Spar Over Piracy Bill PRO IP's supporters testify in Washington that the act will curb counterfeit bags and DVDs. Critics fear it will hurt fair use and new media models.
InternetNews December 13, 2007 Kenneth Corbin	More Scrutiny For Google-DoubleClick Merger Privacy advocates ratchet up the rhetoric over the FTC's review of the Google-DoubleClick merger.
InternetNews December 13, 2007	Groups Ask FTC Chief to Recuse Self in Google Deal Consumer groups say head regulator has ties to a law firm representing DoubleClick.
InternetNews December 12, 2007 Sean Gallagher	Coalition Wants TV 'White Spaces' For Broadband The Google-backed Wireless Innovation Alliance calls for the FCC to open up the gaps between existing television channels for Internet use.
The Motley Fool December 12, 2007 Brian Orelli	Congress Calls Out Merck and Schering-Plough The House of Representatives wants to know what's taking these pharmaceutical companies so long to release trial data from their ENHANCE clinical trial.
The Motley Fool December 12, 2007 Brian Lawler	Patent Bill Is No Panacea A new bill that was meant to strengthen the patent and other intellectual-property rights of drugmakers doesn't do enough to encourage pharma innovation.
<Older 7531-7540 Newer> Return to current articles.